Standard
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells. / Mortensen, Rasmus Erik Johansson; Holmström, Morten Orebo; Andersen, Mads Hald.
In:
Cellular and Molecular Immunology, Vol. 18, No. 11, 2021, p. 2575-2577.
Research output: Contribution to journal › Comment/debate › Research › peer-review
Harvard
Mortensen, REJ, Holmström, MO
& Andersen, MH 2021, '
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells',
Cellular and Molecular Immunology, vol. 18, no. 11, pp. 2575-2577.
https://doi.org/10.1038/s41423-021-00770-0APA
Mortensen, R. E. J., Holmström, M. O.
, & Andersen, M. H. (2021).
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells.
Cellular and Molecular Immunology,
18(11), 2575-2577.
https://doi.org/10.1038/s41423-021-00770-0Vancouver
Mortensen REJ, Holmström MO
, Andersen MH.
Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells.
Cellular and Molecular Immunology. 2021;18(11):2575-2577.
https://doi.org/10.1038/s41423-021-00770-0Author
Mortensen, Rasmus Erik Johansson ; Holmström, Morten Orebo ; Andersen, Mads Hald. / Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells. In: Cellular and Molecular Immunology. 2021 ; Vol. 18, No. 11. pp. 2575-2577.
Bibtex
@article{b5a253bbb6c6444c9361710a9e5268b2,
title = "Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells",
author = "Mortensen, {Rasmus Erik Johansson} and Holmstr{\"o}m, {Morten Orebo} and Andersen, {Mads Hald}",
note = "Funding Information: This project was supported by Danish Health Authority grant “Empowering Cancer Immunotherapy in Denmark” (grant number 4-1612-236/8), the Copenhagen University Hospital, Herlev, and Gentofte and through a research funding agreement between IO Biotech ApS and the National Center for Cancer Immune Therapy (CCIT-DK). We greatly appreciate the tremendous technical support from Merete Jonassen.",
year = "2021",
doi = "10.1038/s41423-021-00770-0",
language = "English",
volume = "18",
pages = "2575--2577",
journal = "Cellular & Molecular Immunology",
issn = "1672-7681",
publisher = "nature publishing group",
number = "11",
}
RIS
TY - JOUR
T1 - Characterization of TGFβ-specific CD4+T cells through the modulation of TGFβ expression in malignant myeloid cells
AU - Mortensen, Rasmus Erik Johansson
AU - Holmström, Morten Orebo
AU - Andersen, Mads Hald
N1 - Funding Information:
This project was supported by Danish Health Authority grant “Empowering Cancer Immunotherapy in Denmark” (grant number 4-1612-236/8), the Copenhagen University Hospital, Herlev, and Gentofte and through a research funding agreement between IO Biotech ApS and the National Center for Cancer Immune Therapy (CCIT-DK). We greatly appreciate the tremendous technical support from Merete Jonassen.
PY - 2021
Y1 - 2021
U2 - 10.1038/s41423-021-00770-0
DO - 10.1038/s41423-021-00770-0
M3 - Comment/debate
C2 - 34526675
AN - SCOPUS:85115194755
VL - 18
SP - 2575
EP - 2577
JO - Cellular & Molecular Immunology
JF - Cellular & Molecular Immunology
SN - 1672-7681
IS - 11
ER -
